key: cord-1035754-3wib4jxw
authors: Cheung, Ka Shing; Leung, Wai K.
title: Reply to GASTRO-D-20-01116
date: 2020-09-22
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.09.019
sha: a69a565513011395f84c75e639f10d3bd68cd127
doc_id: 1035754
cord_uid: 3wib4jxw

nan

We thank Xing et al 1 for their findings on the comparison of detection rates of different samples (nasopharyngeal swabs, sputum samples, gastrointestinal samples, and others like urine and bronchoalveolar lavage) for SARS-CoV2 in response to our recent study. 2 In their cohort of 144 COVID-19 patients, the positive rate of nasopharyngeal swab (56.7%) was similar to that of sputum (50.0%), but was higher than stool samples (17.2%) and anal swab (22.6%). Therefore, they concluded that the performance of gastrointestinal samples for SARS-CoV-2 RNA was poor.

Their findings were in fact in line with our findings 2 and the summary by the American Gastroenterological Association Institute. 3 In the Hong Kong cohort, 15.3% had stool tested positive for viral RNA on presentation. 2 Those who had diarrhea had a higher frequency of stool viral RNA positivity than those who did not (38.5% vs 8.7%). As in our meta-analysis, Although viral RNA could be detected in stool, it is imperative to emphasize that testing of upper respiratory specimens should remain the initial test for COVID-19. 4 after the respiratory samples were tested positive. 6 Stool viral RNA could also be detected during the late phase of illness 7 and for up to ≥33 days from symptom onset in our metaanalysis. 2 Among the 124 patients who had serial positive test results in both respiratory and stool specimens in our meta-analysis, 70.3% had persistent positive stool viral RNA despite negative respiratory samples (eFigure 6 of the article). Taken together, all these data suggest a temporal difference in the detection rates of viral RNA in respiratory and gastrointestinal samples.

In conclusion, we agree that gastrointestinal sample should not be used as the only test for diagnosis of COVID-19, but it may be useful in patients with delayed presentation or those with gastrointestinal symptoms. Nonetheless, the temporal patterns of viral shedding in different types of specimens as well as the potential fecal-oral transmission risk of SARS-CoV2 should be the main focus of these findings, rather than over-emphasizing the relatively low diagnostic yield of stool viral RNA.

. J o u r n a l P r e -p r o o f

SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

Laboratory Diagnosis of COVID-19: Current Issues and Challenges

Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease

Gastrointestinal features in COVID-19 and the possibility of faecal transmission

Evidence for Gastrointestinal Infection of SARS-CoV-2

Author names in bold designate shared co-first authorship